Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by Accord Healthcare Inc., priced at $0.5924 per GM under NDC 16729042101. Its NADAC has been published 359 times since Jul 10, 2019.
FDA first approved this application on Jan 31, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
Manufacturer
Accord Healthcare Inc.NDC
16729042101
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA211688FDA Approved
1/31/2019
TE Code
AB
On Market Since
5/31/2019
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 359 times since Jul 10, 2019, and over the history we have for it it has declined 85.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5924 per GM |
|---|---|
| All-time high | $4.2440 (Jun 10, 2020) |
| All-time low | $0.5757 (Apr 22, 2026) |
| 52-week high | $0.7337 |
| 52-week low | $0.5757 |
| Median price | $1.2898 |
| Average price | $1.9156 |
| Largest weekly change | +75.9% (Jan 18, 2023) |
| Weeks tracked | 359 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
-9.3%
1Y
-18.2%
3Y
-40.4%
5Y
-77.3%
All
-85.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Accord Healthcare Inc., is $0.5924 per GM (NDC 16729042101), effective May 20, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 85.6%. It has been tracked across 359 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Jul 10, 2019, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5757 (Apr 22, 2026) to a high of $4.2440 (Jun 10, 2020), with a median of $1.2898 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 0.03% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 16729042101) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.